| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,633,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,434,166 |
Avg
Vol: |
659,190 |
| 52
Week Range: |
$21.74 - $21.74 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Marth William S |
Director |
– • – |
2013-06-05 |
4 |
A |
$10.46 |
$29,999 |
D/D |
2,868 |
41,159 |
|
- |
|
| Marth William S |
Director |
– • – |
2013-06-03 |
4 |
B |
$10.23 |
$102,300 |
D/D |
10,000 |
38,291 |
2.39 |
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(454) |
30,076 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,250) |
30,530 |
|
- |
|
| Henderson Lori M |
VP, general counsel |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(477) |
47,505 |
|
- |
|
| Henderson Lori M |
VP, general counsel |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,458) |
47,982 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(454) |
55,386 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,250) |
55,840 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, CEO & President |
• • • |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,667) |
2,745,983 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-05-29 |
4 |
S |
$11.26 |
$9,008 |
D/D |
(800) |
31,780 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-05-22 |
4 |
S |
$10.97 |
$82,275 |
D/D |
(7,500) |
57,090 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-05-22 |
4 |
OE |
$2.93 |
$21,975 |
D/D |
7,500 |
64,590 |
|
- |
|
| D Ambra Constance M |
10% Owner |
– – • |
2013-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
2,679,318 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, CEO & President |
• • • |
2013-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
2,752,650 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-05-10 |
4 |
S |
$10.40 |
$12,480 |
D/D |
(1,200) |
32,580 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-03-19 |
4 |
S |
$9.91 |
$2,557 |
D/D |
(258) |
57,090 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-19 |
4 |
S |
$9.91 |
$1,784 |
D/D |
(180) |
33,780 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-03-18 |
4 |
S |
$9.98 |
$2,555 |
D/D |
(256) |
57,348 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-18 |
4 |
S |
$9.98 |
$2,485 |
D/D |
(249) |
33,960 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-03-13 |
4 |
S |
$10.69 |
$9,108 |
D/D |
(852) |
57,604 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-12 |
4 |
S |
$10.75 |
$7,278 |
D/D |
(677) |
34,209 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-03-12 |
4 |
S |
$10.73 |
$18,942 |
D/D |
(1,764) |
58,456 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2013-03-11 |
4 |
S |
$10.25 |
$36,265 |
D/D |
(3,538) |
60,220 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-07 |
4 |
S |
$9.56 |
$9,560 |
D/D |
(1,000) |
34,886 |
|
- |
|
| D Ambra Constance M |
10% Owner |
– – • |
2013-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,200 |
2,686,318 |
|
- |
|
620 Records found
|
|
Page 15 of 25 |
|
|
